Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...

Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...

With an in-line performance expected in Q3, ABT stock may trade sideways next week. However, we would watch out for its ...

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

told me we could use the continuous glucose monitor results to optimize my energy levels so I could avoid spikes and crashes. More and more people are talking abut the monitoring device ...

She was wearing a diabetes monitor patch, also called as the blood sugar monitor patch. The monitor patch is a small wearable ...

Senseonics' Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...